Table of Contents Chapter 1 Overview of Spasticity Treatment 1.1 Definition of Spasticity Treatment in This Report 1.2 Commercial Types of Spasticity Treatment 1.2.1 Physical Treatment 1.2.2 Medicine Treatment 1.3 Downstream Application of Spasticity Treatment 1.3.1 Children 1.3.2 Adults 1.4 Development History of Spasticity Treatment 1.5 Market Status and Trend of Spasticity Treatment 2013-2023 1.5.1 Global Spasticity Treatment Market Status and Trend 2013-2023 1.5.2 Regional Spasticity Treatment Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Spasticity Treatment 2013-2017 2.2 Sales Market of Spasticity Treatment by Regions 2.2.1 Sales Volume of Spasticity Treatment by Regions 2.2.2 Sales Value of Spasticity Treatment by Regions 2.3 Production Market of Spasticity Treatment by Regions 2.4 Global Market Forecast of Spasticity Treatment 2018-2023 2.4.1 Global Market Forecast of Spasticity Treatment 2018-2023 2.4.2 Market Forecast of Spasticity Treatment by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Spasticity Treatment by Types 3.2 Sales Value of Spasticity Treatment by Types 3.3 Market Forecast of Spasticity Treatment by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Spasticity Treatment by Downstream Industry 4.2 Global Market Forecast of Spasticity Treatment by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Spasticity Treatment Market Status by Countries 5.1.1 North America Spasticity Treatment Sales by Countries (2013-2017) 5.1.2 North America Spasticity Treatment Revenue by Countries (2013-2017) 5.1.3 United States Spasticity Treatment Market Status (2013-2017) 5.1.4 Canada Spasticity Treatment Market Status (2013-2017) 5.1.5 Mexico Spasticity Treatment Market Status (2013-2017) 5.2 North America Spasticity Treatment Market Status by Manufacturers 5.3 North America Spasticity Treatment Market Status by Type (2013-2017) 5.3.1 North America Spasticity Treatment Sales by Type (2013-2017) 5.3.2 North America Spasticity Treatment Revenue by Type (2013-2017) 5.4 North America Spasticity Treatment Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Spasticity Treatment Market Status by Countries 6.1.1 Europe Spasticity Treatment Sales by Countries (2013-2017) 6.1.2 Europe Spasticity Treatment Revenue by Countries (2013-2017) 6.1.3 Germany Spasticity Treatment Market Status (2013-2017) 6.1.4 UK Spasticity Treatment Market Status (2013-2017) 6.1.5 France Spasticity Treatment Market Status (2013-2017) 6.1.6 Italy Spasticity Treatment Market Status (2013-2017) 6.1.7 Russia Spasticity Treatment Market Status (2013-2017) 6.1.8 Spain Spasticity Treatment Market Status (2013-2017) 6.1.9 Benelux Spasticity Treatment Market Status (2013-2017) 6.2 Europe Spasticity Treatment Market Status by Manufacturers 6.3 Europe Spasticity Treatment Market Status by Type (2013-2017) 6.3.1 Europe Spasticity Treatment Sales by Type (2013-2017) 6.3.2 Europe Spasticity Treatment Revenue by Type (2013-2017) 6.4 Europe Spasticity Treatment Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Spasticity Treatment Market Status by Countries 7.1.1 Asia Pacific Spasticity Treatment Sales by Countries (2013-2017) 7.1.2 Asia Pacific Spasticity Treatment Revenue by Countries (2013-2017) 7.1.3 China Spasticity Treatment Market Status (2013-2017) 7.1.4 Japan Spasticity Treatment Market Status (2013-2017) 7.1.5 India Spasticity Treatment Market Status (2013-2017) 7.1.6 Southeast Asia Spasticity Treatment Market Status (2013-2017) 7.1.7 Australia Spasticity Treatment Market Status (2013-2017) 7.2 Asia Pacific Spasticity Treatment Market Status by Manufacturers 7.3 Asia Pacific Spasticity Treatment Market Status by Type (2013-2017) 7.3.1 Asia Pacific Spasticity Treatment Sales by Type (2013-2017) 7.3.2 Asia Pacific Spasticity Treatment Revenue by Type (2013-2017) 7.4 Asia Pacific Spasticity Treatment Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Spasticity Treatment Market Status by Countries 8.1.1 Latin America Spasticity Treatment Sales by Countries (2013-2017) 8.1.2 Latin America Spasticity Treatment Revenue by Countries (2013-2017) 8.1.3 Brazil Spasticity Treatment Market Status (2013-2017) 8.1.4 Argentina Spasticity Treatment Market Status (2013-2017) 8.1.5 Colombia Spasticity Treatment Market Status (2013-2017) 8.2 Latin America Spasticity Treatment Market Status by Manufacturers 8.3 Latin America Spasticity Treatment Market Status by Type (2013-2017) 8.3.1 Latin America Spasticity Treatment Sales by Type (2013-2017) 8.3.2 Latin America Spasticity Treatment Revenue by Type (2013-2017) 8.4 Latin America Spasticity Treatment Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Spasticity Treatment Market Status by Countries 9.1.1 Middle East and Africa Spasticity Treatment Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Spasticity Treatment Revenue by Countries (2013-2017) 9.1.3 Middle East Spasticity Treatment Market Status (2013-2017) 9.1.4 Africa Spasticity Treatment Market Status (2013-2017) 9.2 Middle East and Africa Spasticity Treatment Market Status by Manufacturers 9.3 Middle East and Africa Spasticity Treatment Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Spasticity Treatment Sales by Type (2013-2017) 9.3.2 Middle East and Africa Spasticity Treatment Revenue by Type (2013-2017) 9.4 Middle East and Africa Spasticity Treatment Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Spasticity Treatment 10.1 Global Economy Situation and Trend Overview 10.2 Spasticity Treatment Downstream Industry Situation and Trend Overview Chapter 11 Spasticity Treatment Market Competition Status by Major Manufacturers 11.1 Production Volume of Spasticity Treatment by Major Manufacturers 11.2 Production Value of Spasticity Treatment by Major Manufacturers 11.3 Basic Information of Spasticity Treatment by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Spasticity Treatment Major Manufacturer 11.3.2 Employees and Revenue Level of Spasticity Treatment Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Spasticity Treatment Major Manufacturers Introduction and Market Data 12.1 Codman & Shurtleff 12.1.1 Company profile 12.1.2 Representative Spasticity Treatment Product 12.1.3 Spasticity Treatment Sales, Revenue, Price and Gross Margin of Codman & Shurtleff 12.2 Medtronic 12.2.1 Company profile 12.2.2 Representative Spasticity Treatment Product 12.2.3 Spasticity Treatment Sales, Revenue, Price and Gross Margin of Medtronic 12.3 Sanofi 12.3.1 Company profile 12.3.2 Representative Spasticity Treatment Product 12.3.3 Spasticity Treatment Sales, Revenue, Price and Gross Margin of Sanofi 12.4 InMed Pharmaceuticals 12.4.1 Company profile 12.4.2 Representative Spasticity Treatment Product 12.4.3 Spasticity Treatment Sales, Revenue, Price and Gross Margin of InMed Pharmaceuticals 12.5 Ipsen 12.5.1 Company profile 12.5.2 Representative Spasticity Treatment Product 12.5.3 Spasticity Treatment Sales, Revenue, Price and Gross Margin of Ipsen 12.6 Orient Pharma 12.6.1 Company profile 12.6.2 Representative Spasticity Treatment Product 12.6.3 Spasticity Treatment Sales, Revenue, Price and Gross Margin of Orient Pharma 12.7 Taj Pharmaceuticals 12.7.1 Company profile 12.7.2 Representative Spasticity Treatment Product 12.7.3 Spasticity Treatment Sales, Revenue, Price and Gross Margin of Taj Pharmaceuticals 12.8 MediciNova 12.8.1 Company profile 12.8.2 Representative Spasticity Treatment Product 12.8.3 Spasticity Treatment Sales, Revenue, Price and Gross Margin of MediciNova 12.9 Genentech 12.9.1 Company profile 12.9.2 Representative Spasticity Treatment Product 12.9.3 Spasticity Treatment Sales, Revenue, Price and Gross Margin of Genentech Chapter 13 Upstream and Downstream Market Analysis of Spasticity Treatment 13.1 Industry Chain of Spasticity Treatment 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Spasticity Treatment 14.1 Cost Structure Analysis of Spasticity Treatment 14.2 Raw Materials Cost Analysis of Spasticity Treatment 14.3 Labor Cost Analysis of Spasticity Treatment 14.4 Manufacturing Expenses Analysis of Spasticity Treatment Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Physical Treatment Table Advantage and Disadvantage of Medicine Treatment Table Sales Volume of Spasticity Treatment by Regions 2013-2017 Table Sales Value of Spasticity Treatment by Regions 2013-2017 Table Production Volume of Spasticity Treatment by Regions 2013-2017 Table Global Sales Volume of Spasticity Treatment by Regions 2018-2023 Table Global Sales Value of Spasticity Treatment by Regions 2018-2023 Table Global Production Volume of Spasticity Treatment by Regions 2018-2023 Table Sales Volume of Spasticity Treatment by Types 2013-2017 Table Sales Value of Spasticity Treatment by Types 2013-2017 Table Sales Volume Forecast of Spasticity Treatment by Types 2018-2023 Table Sales Value Forecast of Spasticity Treatment by Types 2018-2023 Table Sales Volume of Spasticity Treatment by Downstream Industry 2013-2017 Table Sales Volume Forecast of Spasticity Treatment by Downstream Industry 2018-2023 Table North America Spasticity Treatment Sales by Countries (2013-2017) Table North America Spasticity Treatment Sales Share by Countries (2013-2017) Table North America Spasticity Treatment Revenue by Countries (2013-2017) Table North America Spasticity Treatment Revenue Market Share by Countries (2013-2017) Table North America Spasticity Treatment Sales by Type (2013-2017) Table North America Spasticity Treatment Sales Share by Type (2013-2017) Table North America Spasticity Treatment Revenue by Type (2013-2017) Table North America Spasticity Treatment Revenue Share by Type (2013-2017) Table North America Spasticity Treatment Sales by Downstream Industry (2013-2017) Table North America Spasticity Treatment Sales Share by Downstream Industry (2013-2017) Table Europe Spasticity Treatment Sales by Countries (2013-2017) Table Europe Spasticity Treatment Sales Share by Countries (2013-2017) Table Europe Spasticity Treatment Revenue by Countries (2013-2017) Table Europe Spasticity Treatment Revenue Market Share by Countries (2013-2017) Table Europe Spasticity Treatment Sales by Type (2013-2017) Table Europe Spasticity Treatment Sales Share by Type (2013-2017) Table Europe Spasticity Treatment Revenue by Type (2013-2017) Table Europe Spasticity Treatment Revenue Share by Type (2013-2017) Table Europe Spasticity Treatment Sales by Downstream Industry (2013-2017) Table Europe Spasticity Treatment Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Spasticity Treatment Sales by Countries (2013-2017) Table Asia Pacific Spasticity Treatment Sales Share by Countries (2013-2017) Table Asia Pacific Spasticity Treatment Revenue by Countries (2013-2017) Table Asia Pacific Spasticity Treatment Revenue Market Share by Countries (2013-2017) Table Asia Pacific Spasticity Treatment Sales by Type (2013-2017) Table Asia Pacific Spasticity Treatment Sales Share by Type (2013-2017) Table Asia Pacific Spasticity Treatment Revenue by Type (2013-2017) Table Asia Pacific Spasticity Treatment Revenue Share by Type (2013-2017) Table Asia Pacific Spasticity Treatment Sales by Downstream Industry (2013-2017) Table Asia Pacific Spasticity Treatment Sales Share by Downstream Industry (2013-2017) Table Latin America Spasticity Treatment Sales by Countries (2013-2017) Table Latin America Spasticity Treatment Sales Share by Countries (2013-2017) Table Latin America Spasticity Treatment Revenue by Countries (2013-2017) Table Latin America Spasticity Treatment Revenue Market Share by Countries (2013-2017) Table Latin America Spasticity Treatment Sales by Type (2013-2017) Table Latin America Spasticity Treatment Sales Share by Type (2013-2017) Table Latin America Spasticity Treatment Revenue by Type (2013-2017) Table Latin America Spasticity Treatment Revenue Share by Type (2013-2017) Table Latin America Spasticity Treatment Sales by Downstream Industry (2013-2017) Table Latin America Spasticity Treatment Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Spasticity Treatment Sales by Regions (2013-2017) Table Middle East and Africa Spasticity Treatment Sales Share by Regions (2013-2017) Table Middle East and Africa Spasticity Treatment Revenue by Regions (2013-2017) Table Middle East and Africa Spasticity Treatment Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Spasticity Treatment Sales by Type (2013-2017) Table Middle East and Africa Spasticity Treatment Sales Share by Type (2013-2017) Table Middle East and Africa Spasticity Treatment Revenue by Type (2013-2017) Table Middle East and Africa Spasticity Treatment Revenue Share by Type (2013-2017) Table Middle East and Africa Spasticity Treatment Sales by Downstream Industry (2013-2017) Table Middle East and Africa Spasticity Treatment Sales Share by Downstream Industry (2013-2017) Table Production Volume of Spasticity Treatment by Major Manufacturers 2013-2017 Table Production Value of Spasticity Treatment by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Spasticity Treatment Major Manufacturer Table Employees and Revenue Level of Spasticity Treatment Major Manufacturer Table Representative Spasticity Treatment Product One of Codman & Shurtleff Table Representative Spasticity Treatment Product Two of Codman & Shurtleff Table Spasticity Treatment Sales, Revenue, Price and Gross Margin of Codman & Shurtleff 2013-2017 Table Representative Spasticity Treatment Product One of Medtronic Table Representative Spasticity Treatment Product Two of Medtronic Table Spasticity Treatment Sales, Revenue, Price and Gross Margin of Medtronic 2013-2017 Table Representative Spasticity Treatment Product One of Sanofi Table Representative Spasticity Treatment Product Two of Sanofi Table Spasticity Treatment Sales, Revenue, Price and Gross Margin of Sanofi 2013-2017 Table Representative Spasticity Treatment Product One of InMed Pharmaceuticals Table Representative Spasticity Treatment Product Two of InMed Pharmaceuticals Table Spasticity Treatment Sales, Revenue, Price and Gross Margin of InMed Pharmaceuticals 2013-2017 Table Representative Spasticity Treatment Product One of Ipsen Table Representative Spasticity Treatment Product Two of Ipsen Table Spasticity Treatment Sales, Revenue, Price and Gross Margin of Ipsen 2013-2017 Table Representative Spasticity Treatment Product One of Orient Pharma Table Representative Spasticity Treatment Product Two of Orient Pharma Table Spasticity Treatment Sales, Revenue, Price and Gross Margin of Orient Pharma 2013-2017 Table Representative Spasticity Treatment Product One of Taj Pharmaceuticals Table Representative Spasticity Treatment Product Two of Taj Pharmaceuticals Table Spasticity Treatment Sales, Revenue, Price and Gross Margin of Taj Pharmaceuticals 2013-2017 Table Representative Spasticity Treatment Product One of MediciNova Table Representative Spasticity Treatment Product Two of MediciNova Table Spasticity Treatment Sales, Revenue, Price and Gross Margin of MediciNova 2013-2017 Table Representative Spasticity Treatment Product One of Genentech Table Representative Spasticity Treatment Product Two of Genentech Table Spasticity Treatment Sales, Revenue, Price and Gross Margin of Genentech 2013-2017